Blackstone Inc Cabaletta Bio, Inc. Transaction History

Blackstone Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$16.79 - $25.38 $5.05 Million - $7.63 Million	-300,714 Reduced 86.54%	46,780 $798,000
Q4 2023 Feb 14, 2024	BUY	$12.21 - $23.36 $4.24 Million - $8.12 Million	347,494 New	347,494 $7.89 Million
Q2 2023 Aug 14, 2023	SELL	$7.65 - $13.95 $120,418 - $219,586	-15,741 Reduced 3.06%	498,779 $6.44 Million
Q1 2023 May 15, 2023	SELL	$7.08 - $12.62 $5.21 Million - $9.28 Million	-735,480 Reduced 58.84%	514,520 $4.26 Million
Q4 2022 Feb 14, 2023	BUY	$0.64 - $9.3 $800,000 - $11.6 Million	1,250,000 New	1,250,000 $11.6 Million

127

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $79.5M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

Stay updated on Blackstone Inc with notifications on news.